Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cognition Therapeutics Inc (CGTX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 22,041,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Cognition Therapeutics is a clinical-stage biopharmaceutical company. Co. is developing a pipeline of small molecule product candidates that are designed to target the o-2 (sigma-2) receptor (S2R) complex, a key regulator of the cellular damage response for diseases such as Alzheimer's disease, dry Age-Related Macular Degeneration (AMD), geographic atrophy (a form of dry AMD), and other conditions. Co.'s main product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. Co. is initially focused on the development of CT1812 for the treatment of AD by targeting the accumulation of B-amyloid.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 5,700 5,700 5,700 3,214,328
Total Buy Value $9,975 $9,975 $9,975 $3,951,055
Total People Bought 1 1 1 5
Total Buy Transactions 1 1 1 10
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 25
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wallace Peggy Director   –       •      –    2022-09-27 4 A $0.00 $0 D/D 22,461 25,461     -
   Golden Seeds Cognition Therapeutics Llc 10% Owner   –       –       •   2022-09-27 4 D $0.00 $0 D/D (2,489,682) 0     -
   Bios Fund Iii Nt, Lp 10% Owner   –       –       •   2021-10-13 4/A A $0.00 $0 D/D 1,424,014 1,424,014     -
   Kreis Leslie W. 10% Owner   –       –       •   2021-10-13 4/A A $0.00 $0 I/I 1,424,014 1,424,014     -
   Wallace Peggy Director   –       •      –    2021-10-13 4 B $12.00 $36,000 D/D 3,000 3,000 2.39     -
   Breedlove Mark H. Director   –       •      –    2021-10-13 4 S $12.00 $141 I/I (12) 404,439     -
   Breedlove Mark H. Director   –       •      –    2021-10-13 4 A $0.00 $139 I/I 404,451 404,451     -
   Bios Memory Spv I, Lp 10% Owner   –       –       •   2021-10-13 4 A $0.00 $0 I/I 2,265,423 60,065     -
   Bios Memory Spv I, Lp 10% Owner   –       –       •   2021-10-13 4 B $12.00 $2,280,000 I/I 190,000 899,905 1.5     -
   Bios Memory Spv I, Lp 10% Owner   –       –       •   2021-10-13 4 S $12.00 $1,083 I/I (90) 385,248     -
   Bios Memory Spv I, Lp 10% Owner   –       –       •   2021-10-13 4 OE $0.03 $1,072 I/I 33,495 385,339     -
   Bios Memory Spv I, Lp 10% Owner   –       –       •   2021-10-13 4 A $0.00 $0 D/D 1,424,014 1,424,014     -
   Golden Seeds Cognition Therapeutics Llc 10% Owner   –       –       •   2021-10-13 4 A $0.00 $0 D/D 2,477,449 2,489,691     -
   Golden Seeds Cognition Therapeutics Llc 10% Owner   –       –       •   2021-10-13 4 S $12.00 $397 D/D (33) 2,177,985     -
   Golden Seeds Cognition Therapeutics Llc 10% Owner   –       –       •   2021-10-13 4 OE $0.03 $393 D/D 12,276 2,178,019     -
   Ogden Cap Associates, Llc 10% Owner   –       –       •   2021-10-13 4 S $12.00 $889 D/D (74) 2,210,377     -
   Ogden Cap Associates, Llc 10% Owner   –       –       •   2021-10-13 4 OE $0.03 $879 D/D 27,471 2,210,452     -
   Ogden Cap Associates, Llc 10% Owner   –       –       •   2021-10-13 4 A $0.00 $0 D/D 2,182,981 2,182,981     -
   Fletcher Aaron G.l. Director   –       •      –    2021-10-13 4 A $0.00 $0 I/I 3,689,437 60,065     -
   Fletcher Aaron G.l. Director   –       •      –    2021-10-13 4 B $12.00 $2,280,000 I/I 190,000 899,905 2.1     -
   Fletcher Aaron G.l. Director   –       •      –    2021-10-13 4 S $12.00 $1,083 I/I (90) 385,248     -
   Fletcher Aaron G.l. Director   –       •      –    2021-10-13 4 OE $0.03 $1,072 I/I 33,495 385,339     -
   Ricciardi Lisa CEO & President   •       •      –    2021-10-13 4 B $12.00 $150,000 D/D 12,500 12,500 2.81     -
   Obrien James Michael Chief Financial Officer   •       –      –    2021-10-13 4 B $12.00 $60,000 D/D 5,000 5,000 2.74     -
   Breedlove Mark H. Director   –       •      –    2021-10-07 3 IO $0.00 $0 D/D 0 7,611     -
  25 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us